## **Core Concept**
The question tests knowledge of antihypertensive drugs and their safety profiles during pregnancy. Pregnancy-induced hypertension is a significant concern, and the choice of antihypertensive medication is crucial to ensure both maternal and fetal safety. Certain antihypertensive drugs are contraindicated in pregnancy due to potential adverse effects on the fetus.

## **Why the Correct Answer is Right**
The correct answer, , refers to ACE inhibitors (Angiotensin-Converting Enzyme inhibitors). ACE inhibitors are known to be contraindicated in pregnancy, particularly in the second and third trimesters, due to the risk of fetal harm. They can cause fetal hypotension, renal failure, and skull hypoplasia. The mechanism involves the inhibition of angiotensin-converting enzyme, which plays a critical role in the renin-angiotensin-aldosterone system. This system is vital for blood pressure regulation and electrolyte balance. In pregnancy, the use of ACE inhibitors can disrupt this system, leading to the aforementioned fetal complications.

## **Why Each Wrong Option is Incorrect**
- **Option A:** - This option might represent a different class of antihypertensive drugs that are considered safe in pregnancy, such as methyldopa, a centrally acting alpha-2 adrenergic agonist.
- **Option B:** - This could represent another class of drugs used in pregnancy, like calcium channel blockers (e.g., nifedipine), which are often used to manage hypertension in pregnant women.
- **Option D:** - This might symbolize labetalol, a mixed alpha/beta blocker commonly used in pregnancy-induced hypertension.

## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that ACE inhibitors and angiotensin receptor blockers (ARBs) are contraindicated in pregnancy due to their association with fetal renal damage and other complications. For pregnant women with hypertension, methyldopa is often considered a first-line treatment due to its long history of safe use in pregnancy.

## **Correct Answer: .**